Operating Margin - Prostatype Genomics AB (F:PGO) - Alpha Spread
P

Prostatype Genomics AB
F:PGO

Watchlist Manager
Prostatype Genomics AB
F:PGO
Watchlist
Price: 0.0012 EUR Market Closed
Market Cap: 1.2m EUR
Have any thoughts about
Prostatype Genomics AB?
Write Note

Operating Margin
Prostatype Genomics AB

-3 727.6%
Current
-5 233%
Average
-8.9%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3 727.6%
=
Operating Profit
-38.1m
/
Revenue
1m

Operating Margin Across Competitors

Country SE
Market Cap 18.8m SEK
Operating Margin
-3 728%
Country US
Market Cap 341.5B USD
Operating Margin
29%
Country US
Market Cap 180.5B USD
Operating Margin
20%
Country US
Market Cap 129B USD
Operating Margin
31%
Country US
Market Cap 123.6B USD
Operating Margin
41%
Country US
Market Cap 105B USD
Operating Margin
37%
Country US
Market Cap 94.1B EUR
Operating Margin
-370%
Country AU
Market Cap 142.3B AUD
Operating Margin
26%
Country US
Market Cap 39.3B EUR
Operating Margin
-33%
Country US
Market Cap 38.5B USD
Operating Margin
-555%
Country US
Market Cap 35.2B USD
Operating Margin
4%

Profitability Report

View the profitability report to see the full profitability analysis for Prostatype Genomics AB.

See Also

Discover More
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-3 727.6%
=
Operating Profit
-38.1m
/
Revenue
1m
What is the Operating Margin of Prostatype Genomics AB?

Based on Prostatype Genomics AB's most recent financial statements, the company has Operating Margin of -3 727.6%.